🇺🇸 FDA
Pipeline program

CX11, Placebo to cx11 40 mg, CX11, Placebo to cx11 80 mg

CX11202

Phase 2 small_molecule active

Quick answer

CX11, Placebo to cx11 40 mg, CX11, Placebo to cx11 80 mg for Type 2 Diabetes Mellitus is a Phase 2 program (small_molecule) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).

Program details

Company
Pharma Mar S.A.
Indication
Type 2 Diabetes Mellitus
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials